Jeffrey Jones

Direttore Tecnico/Scientifico/R&S presso CULLINAN THERAPEUTICS, INC.

Patrimonio netto: 321 739 $ in data 31/05/2024

53 anni

Consumer Services

Health Technology

Finance

Posizioni attive di Jeffrey Jones

Società	Posizione	Inizio	Fine
CULLINAN THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	28/02/2022	-

Società	Posizione	Inizio	Fine
BRISTOL-MYERS SQUIBB COMPANY	Direttore Tecnico/Scientifico/R&S	01/08/2017	01/04/2020
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/04/2020	01/02/2022
The Ohio State University College of Medicine	Corporate Officer/Principal	-	-
Cullinan Oncology LLC Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.	Direttore Tecnico/Scientifico/R&S	01/02/2022	-

University of Michigan Medical School	Doctorate Degree
Fisher College of Business	Masters Business Admin
The University of Texas Health Science Center at Houston	Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
CULLINAN THERAPEUTICS, INC.	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Aziende private	1
Cullinan Oncology LLC Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.	Finance